Edesa Biotech, Inc. (EDSA) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2015: -$4.41M2016: -$4.51M2017: -$4.70M2018: -$1.29M2020: -$4.99M2021: -$13.66M2022: -$12.28M2023: -$6.64M2024: -$4.89M2025: -$7.32M-$7.32M
2015Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$7.32M-49.7%
2024-$4.89M+26.3%
2023-$6.64M+46.0%
2022-$12.28M+10.1%
2021-$13.66M-174.0%
2020-$4.99M
2018-$1.29M+72.6%
2017-$4.70M-4.3%
2016-$4.51M-2.1%
2015-$4.41M